OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
Zemene Demelash Kifle, Akeberegn Gorems Ayele, Engidaw Fentahun Enyew
Journal of Environmental and Public Health (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 33
Zemene Demelash Kifle, Akeberegn Gorems Ayele, Engidaw Fentahun Enyew
Journal of Environmental and Public Health (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 74
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 74
Therapeutics for COVID-19 and post COVID-19 complications: An update
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 69
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 69
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 54
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 54
The tumor therapeutic potential of long non-coding RNA delivery and targeting
Shuo Han, Xinru Chen, Leaf Huang
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1371-1382
Open Access | Times Cited: 27
Shuo Han, Xinru Chen, Leaf Huang
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1371-1382
Open Access | Times Cited: 27
In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19
Reham F. Barghash, Iten M. Fawzy, Vaisali Chandrasekar, et al.
Coatings (2021) Vol. 11, Iss. 11, pp. 1273-1273
Open Access | Times Cited: 28
Reham F. Barghash, Iten M. Fawzy, Vaisali Chandrasekar, et al.
Coatings (2021) Vol. 11, Iss. 11, pp. 1273-1273
Open Access | Times Cited: 28
Repurposing of gastric cancer drugs against COVID-19
Charu Sonkar, Pawan Kumar Doharey, Anuranjan Singh Rathore, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104826-104826
Open Access | Times Cited: 22
Charu Sonkar, Pawan Kumar Doharey, Anuranjan Singh Rathore, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104826-104826
Open Access | Times Cited: 22
Analytical approaches for determination of COVID-19 candidate drugs in human biological matrices
Rabee Mahdavi, Zahra Talebpour
TrAC Trends in Analytical Chemistry (2023) Vol. 160, pp. 116964-116964
Open Access | Times Cited: 8
Rabee Mahdavi, Zahra Talebpour
TrAC Trends in Analytical Chemistry (2023) Vol. 160, pp. 116964-116964
Open Access | Times Cited: 8
Antimicrobial and anti-SARS-CoV-2 activities of smart daclatasvir-chitosan/gelatin nanoparticles-in-PLLA nanofibrous medical textiles; in vitro, and in vivo study
Isra H. Ali, Akram M. Elkashlan, Mohamed A. Hammad, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127350-127350
Closed Access | Times Cited: 8
Isra H. Ali, Akram M. Elkashlan, Mohamed A. Hammad, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127350-127350
Closed Access | Times Cited: 8
Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?
Vladimir Vimberg
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1227-1227
Open Access | Times Cited: 17
Vladimir Vimberg
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1227-1227
Open Access | Times Cited: 17
Repurposing – second life for drugs
Porkodi Ayyar, Umamaheswari Subramanian
Pharmacia (2022) Vol. 69, Iss. 1, pp. 51-59
Open Access | Times Cited: 12
Porkodi Ayyar, Umamaheswari Subramanian
Pharmacia (2022) Vol. 69, Iss. 1, pp. 51-59
Open Access | Times Cited: 12
In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19
Takaharu Asano, Sarvesh Chelvanambi, Julius L. Decano, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Takaharu Asano, Sarvesh Chelvanambi, Julius L. Decano, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 11
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, et al.
Drug Metabolism and Personalized Therapy (2023)
Open Access | Times Cited: 6
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, et al.
Drug Metabolism and Personalized Therapy (2023)
Open Access | Times Cited: 6
NICLOSAMIDE: A POTENTIAL TREATMENT OPTION FOR COVID-19
S. K. Vibhute, Aditi Kasar, HRISHIKESH MAHALE, et al.
International Journal of Applied Pharmaceutics (2023), pp. 50-56
Open Access | Times Cited: 5
S. K. Vibhute, Aditi Kasar, HRISHIKESH MAHALE, et al.
International Journal of Applied Pharmaceutics (2023), pp. 50-56
Open Access | Times Cited: 5
SARS-CoV-2 Papain-like Protease Responsive ZnO/Daclatasvir-Loaded Chitosan/Gelatin Nanofibers as Smart Antimicrobial Medical Textiles: In Silico, In Vitro and Cell Studies
Mohamed Hamdi, Akram M. Elkashlan, Mohamed A. Hammad, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2074-2074
Open Access | Times Cited: 5
Mohamed Hamdi, Akram M. Elkashlan, Mohamed A. Hammad, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2074-2074
Open Access | Times Cited: 5
Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection
Surbhi Garg, Vijay Kumar Singh, Subash Chandra Sonkar, et al.
Clinica Chimica Acta (2022) Vol. 527, pp. 11-16
Open Access | Times Cited: 8
Surbhi Garg, Vijay Kumar Singh, Subash Chandra Sonkar, et al.
Clinica Chimica Acta (2022) Vol. 527, pp. 11-16
Open Access | Times Cited: 8
An Overview of Computational‐Based Strategies for Drug Repositioning
Shalu Verma, Nidhi Nainwal, Alka Singh, et al.
(2024), pp. 81-97
Closed Access | Times Cited: 1
Shalu Verma, Nidhi Nainwal, Alka Singh, et al.
(2024), pp. 81-97
Closed Access | Times Cited: 1
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, et al.
Drug Metabolism and Personalized Therapy (2023) Vol. 38, Iss. 4, pp. 295-307
Open Access | Times Cited: 3
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, et al.
Drug Metabolism and Personalized Therapy (2023) Vol. 38, Iss. 4, pp. 295-307
Open Access | Times Cited: 3
Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled Trial
Sadhna Joglekar, Shivakumar Iyer, Rohit Parate, et al.
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 2, pp. 807-826
Open Access | Times Cited: 5
Sadhna Joglekar, Shivakumar Iyer, Rohit Parate, et al.
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 2, pp. 807-826
Open Access | Times Cited: 5
Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection
Wernér E.G. Müller, Xiaohong Wang, Meik Neufurth, et al.
Progress in molecular and subcellular biology (2022), pp. 145-189
Closed Access | Times Cited: 5
Wernér E.G. Müller, Xiaohong Wang, Meik Neufurth, et al.
Progress in molecular and subcellular biology (2022), pp. 145-189
Closed Access | Times Cited: 5
Rethinking on Using of Traditional Indigenous Medicinal Plants for the Management of Covid-19 In India- A Review
Halavath Ramesh, M. F. Valan
International Journal of Ayurveda and Pharma Research (2021), pp. 53-63
Open Access | Times Cited: 7
Halavath Ramesh, M. F. Valan
International Journal of Ayurveda and Pharma Research (2021), pp. 53-63
Open Access | Times Cited: 7
Drug Repurposing for COVID-19 using Computational Methods
Om Prakash, Feroz Khan
BENTHAM SCIENCE PUBLISHERS eBooks (2023), pp. 161-185
Closed Access | Times Cited: 2
Om Prakash, Feroz Khan
BENTHAM SCIENCE PUBLISHERS eBooks (2023), pp. 161-185
Closed Access | Times Cited: 2
Cocculus hirsutus (L.): Conventional uses, phytochemistry, pharmacological actions and clinical studies
Ashmun Nisha, Arshiya Shamim, Aleza Rizvi, et al.
Annals of Phytomedicine An International Journal (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Ashmun Nisha, Arshiya Shamim, Aleza Rizvi, et al.
Annals of Phytomedicine An International Journal (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Pathogenesis of the SARS Coronavirus-2 and Potential Therapeutic Strategies
Sousan Akrami
JOURNAL OF COMMUNICABLE DISEASES (2022), pp. 202-209
Open Access | Times Cited: 3
Sousan Akrami
JOURNAL OF COMMUNICABLE DISEASES (2022), pp. 202-209
Open Access | Times Cited: 3
Variations of SARS-CoV-2 in the Iranian population and candidate putative drug-like compounds to inhibit the mutated proteins
Zahra Mortezaei, Ali Mohammadian, Mahmood Tavallaei
Heliyon (2022) Vol. 8, Iss. 7, pp. e09910-e09910
Open Access | Times Cited: 3
Zahra Mortezaei, Ali Mohammadian, Mahmood Tavallaei
Heliyon (2022) Vol. 8, Iss. 7, pp. e09910-e09910
Open Access | Times Cited: 3
Non-coding RNAs function as diagnostic biomarkers and therapeutic targets in pulmonary arterial hypertension
Yingqi Wang, Daling Zhu, Hang Yu
Biomedical engineering (2024)
Open Access
Yingqi Wang, Daling Zhu, Hang Yu
Biomedical engineering (2024)
Open Access
